152 related articles for article (PubMed ID: 33604541)
1. Kidney microRNA-21 Expression and Kidney Function in IgA Nephropathy.
Szeto CC; Ng JK; Fung WW; Luk CC; Wang G; Chow KM; Lai KB; Li PK; Lai FM
Kidney Med; 2021; 3(1):76-82.e1. PubMed ID: 33604541
[TBL] [Abstract][Full Text] [Related]
2. Intrarenal expression of microRNAs in patients with IgA nephropathy.
Wang G; Kwan BC; Lai FM; Choi PC; Chow KM; Li PK; Szeto CC
Lab Invest; 2010 Jan; 90(1):98-103. PubMed ID: 19901913
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
[TBL] [Abstract][Full Text] [Related]
4. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
[TBL] [Abstract][Full Text] [Related]
5. Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease.
Szeto CC; Ng JK; Fung WW; Chan GC; Luk CC; Lai KB; Wang G; Chow KM; Mac-Moune Lai F
Clin Chim Acta; 2022 May; 530():81-86. PubMed ID: 35278407
[TBL] [Abstract][Full Text] [Related]
6. Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis.
Wang G; Kwan BC; Lai FM; Choi PC; Chow KM; Li PK; Szeto CC
Am J Hypertens; 2010 Jan; 23(1):78-84. PubMed ID: 19910931
[TBL] [Abstract][Full Text] [Related]
7. Urinary and Kidney Podocalyxin and Podocin Levels in Diabetic Kidney Disease: A Kidney Biopsy Study.
Zeng L; Fung WW; Chan GC; Ng JK; Chow KM; Szeto CC
Kidney Med; 2023 Jan; 5(1):100569. PubMed ID: 36654969
[TBL] [Abstract][Full Text] [Related]
8. Podocyte loss in human hypertensive nephrosclerosis.
Wang G; Lai FM; Kwan BC; Lai KB; Chow KM; Li PK; Szeto CC
Am J Hypertens; 2009 Mar; 22(3):300-6. PubMed ID: 19131934
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy.
Wu J; Chen X; Xie Y; Yamanaka N; Shi S; Wu D; Liu S; Cai G
Nephrol Dial Transplant; 2005 Apr; 20(4):719-27. PubMed ID: 15701667
[TBL] [Abstract][Full Text] [Related]
10. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.
Wang N; Bu R; Duan Z; Zhang X; Chen P; Li Z; Wu J; Cai G; Chen X
PeerJ; 2015; 3():e990. PubMed ID: 26056621
[TBL] [Abstract][Full Text] [Related]
11. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
[TBL] [Abstract][Full Text] [Related]
12. Arteriolar C4d in IgA Nephropathy: A Cohort Study.
Faria B; Canão P; Cai Q; Henriques C; Matos AC; Poppelaars F; Gaya da Costa M; Daha MR; Silva R; Pestana M; Seelen MA
Am J Kidney Dis; 2020 Nov; 76(5):669-678. PubMed ID: 32439421
[TBL] [Abstract][Full Text] [Related]
13. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
14. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy.
Wang G; Kwan BC; Lai FM; Chow KM; Li PK; Szeto CC
Dis Markers; 2011; 30(4):171-9. PubMed ID: 21694443
[TBL] [Abstract][Full Text] [Related]
16. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy.
Wang G; Kwan BC; Lai FM; Chow KM; Kam-Tao Li P; Szeto CC
Dis Markers; 2010; 28(2):79-86. PubMed ID: 20364043
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
Yang L; Zhang X; Peng W; Wei M; Qin W
Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
[TBL] [Abstract][Full Text] [Related]
18. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.
Zhang Y; Sun L; Zhou S; Xu Q; Xu Q; Liu D; Liu L; Hu R; Quan S; Xing G
Kidney Blood Press Res; 2018; 43(2):639-650. PubMed ID: 29698975
[TBL] [Abstract][Full Text] [Related]
19. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
Hu H; Wan Q; Li T; Qi D; Dong X; Xu Y; Chen H; Liu H; Huang H; Wei C; Zhou W; Jiang S; Mo Z; Liao F; Xu Q; He Y
Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study.
Liu Y; Ma X; Lv J; Shi S; Liu L; Chen Y; Zhang H
Am J Kidney Dis; 2014 Nov; 64(5):730-6. PubMed ID: 25134778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
